Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCIENCE GROUP PLC Major Shareholding Notification 2025

Apr 1, 2025

7903_mang_2025-04-01_913b98e2-8845-4616-b7f2-57ec6141c3aa.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0100D

Science Group PLC

01 April 2025

1 April 2025

Science Group plc

(the "Group" or "Science Group")

Increased Shareholding in Ricardo plc

Science Group has further increased its shareholding in Ricardo plc ("Ricardo") to 10,778,684 shares, equivalent to approximately 17.32% of the voting rights. The average cost (including fees) is 233 pence per share. Science Group may or may not increase its shareholding in Ricardo.

Science Group is the second largest shareholder in Ricardo, a British science and technology company with a brand heritage extending over 100 years.  Science Group's position has been set out in the following announcements:

·    17 March 2025: www.sciencegroup.com/news-detail/response-to-ricardo-plc-17-03-25

·    31 March 2025: www.sciencegroup.com/news-detail/update-on-ricardo-plc

- Ends -

For further information:

Science Group plc
Martyn Ratcliffe, Executive Chair Tel: +44 (0) 1223 875 200
Jon Brett, Finance Director www.sciencegroup.com
Canaccord Genuity Limited (Nominated Adviser and Joint Broker)
Simon Bridges, Andrew Potts Tel: +44 (0) 20 7523 8000
MHP
Reg Hoare Tel: +44 (0) 7831 406117
[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQFLFVRVSILVIE